COMMUNIQUÉS West-GlobeNewswire

Pain Therapeutics Announces Appointment of Chief Financial Officer
11/10/2018
AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that Mr. Eric Schoen will join its management team as Chief Financial Officer, [...]
Integrated Cannabis Company, Inc. Announces Fall 2018 Collaboration to Launch CBD Products in the Colorado Market
11/10/2018
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, [...]
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
11/10/2018
MONTRÉAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
Resonant Inc. Appoints Tech and Finance Executive Bob Tirva to its Board of Directors
11/10/2018
- Respected tech industry veteran brings more than 25 years of comprehensive financial expertise - GOLETA, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio [...]
Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis
11/10/2018
TEL AVIV, Israel, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), announced today that a study entitled “MOSPD2: A Novel Therapeutic Target for the Treatment of CNS Inflammation,” is being presented [...]
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract for ESMO 2018 Congress
11/10/2018
- Pelareorep and FOLFIRI/B combination shows superior OS & PFS data in KRAS mutant colorectal cancer compared to historical data - CALGARY, Alberta and SAN DIEGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech [...]
Ogilvy CommonHealth Worldwide’s Johanna Skilling honored as a 2018 Agency Vanguard Award Winner
11/10/2018
PARSIPPANY, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP, www.wpp.com ), today announced Johanna Skilling, head of [...]
Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute Pain
11/10/2018
Anesthetic and Analgesic Drug Products Advisory Committee Meeting October 11, 2018 CHESTERBROOK, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced that NASDAQ has halted trading of the [...]
Axsome Therapeutics to Focus on Growing Core CNS Portfolio; Establishes Axsome Pain and Primary Care Business Unit to Enhance Value of Non-CNS Assets
11/10/2018
Axsome PPC to include three novel, non-opioid, Phase 3-stage product candidates for chronic pain 145 issued Axsome PPC patents, including 21 covering neridronate, provide protection as far as 2036 Indications include [...]
Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President
11/10/2018
TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF ) ("Emblem" or the "Company") today announced additional leadership and operational resources to support the rapid growth of its medical [...]
Emerald Health Therapeutics Promotes Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing
11/10/2018
VICTORIA, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced the promotion of Paul R. Dillman, Jr. to Executive Vice President of [...]
Amicus Therapeutics to Host Analyst Day 2018 Today in New York City
11/10/2018
Management and External Thought Leaders to Highlight Robust Portfolio of Novel Therapies for Rare Metabolic Diseases Webcast Scheduled from 8:30am – 12:30pm E.T. CRANBURY, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Amicus [...]
Tetra Bio-Pharma’s PPP002 on Track After Type C Meeting with FDA
11/10/2018
Food and Drug Administration confirms nonclinical and manufacturing requirements ORLEANS, Ontario, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development ( [...]
Avivagen Announces Distribution Agreement for OxC-beta™ Livestock in Malaysia
11/10/2018
OTTAWA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed its first distribution agreement for OxC-beta™ Livestock in Malaysia. With a total annual feed [...]
Emergent BioSolutions to Release Third Quarter 2018 Financial Results and Conduct a Conference Call on November 1, 2018
11/10/2018
GAITHERSBURG, Md., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 1, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China
11/10/2018
Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China Exclusive Unyvero A50 distribution agreement extended to eight years Significant further contractual minimum purchase [...]
Rule 2.9 Announcement
11/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 October 2018 [...]
NEOVACS ANNOUNCES THE CONTINUATION OF THE DEVELOPMENT OF ITS IFNalpha KINOID IN SOUTH KOREA WITH ITS PARTNER CHONG KUN DANG (CKD) PHARMACEUTICALS
11/10/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE CONTINUATION OF THE DEVELOPMENT OF ITS IFN alpha KINOID IN SOUTH KOREA WITH ITS PARTNER CHONG KUN DANG (CKD) PHARMACEUTICALS Both partners have agreed [...]
NÉOVACS ANNONCE LA POURSUITE DU DÉVELOPPEMENT DE L'IFNalpha KINOIDE EN CORÉE DU SUD, AVEC SON PARTENAIRE CHONG KUN DANG (CKD) PHARMACEUTICAL
11/10/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NÉOVACS ANNONCE LA POURSUITE DU DÉVELOPPEMENT DE L'IFNalpha KINOIDE EN CORÉE DU SUD, AVEC SON PARTENAIRE CHONG KUN DANG (CKD) PHARMACEUTICAL Les deux partenaires ont convenu [...]

Pages